首页> 美国卫生研究院文献>Journal of Clinical Medicine >Analysis of Risk Factors and Long-Term Outcomes in Kidney Transplant Patients with Identified Lymphoceles
【2h】

Analysis of Risk Factors and Long-Term Outcomes in Kidney Transplant Patients with Identified Lymphoceles

机译:肾移植患者鉴定淋巴细胞患者风险因素及长期成果分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The collection of lymphatic fluids (lymphoceles) is a frequent adverse event following renal transplantation. A variety of surgical and medical factors has been linked to this entity, but reliable data on risk factors and long-term outcomes are lacking. This retrospective single-center study included 867 adult transplant recipients who received a kidney transplantation from 2006 to 2015. We evaluated for patient and graft survival, rejection episodes, or detectable donor-specific antibodies (dnDSA) in patients with identified lymphoceles in comparison to controls. We identified 305/867 (35.2%) patients with lymphocele formation, of whom 72/867 (8.3%) needed intervention. Multivariate analysis identified rejection episode as an independent risk factor (OR 1.61, CI 95% 1.17–2.21, p = 0.003) for lymphocele formation, while delayed graft function was independently associated with symptomatic lymphoceles (OR 1.9, CI 95% 1.16–3.12, p = 0.011). Interestingly, there was no difference in detectable dnDSA between groups with a similar graft and patient survival in all groups after 10 years. Lymphoceles frequently occur after transplantation and were found to be independently associated with rejection episodes, while symptomatic lymphoceles were associated with delayed graft function in our cohort. As both are inflammatory processes, they might play a causative role in the formation of lymphoceles. However, development or intervention of lymphoceles did not lead to impaired graft survival in the long-term.
机译:淋巴液(淋巴细胞)的集合是肾移植后经常不良事件。各种外科医疗因素已与该实体有关,但缺乏关于风险因素和长期成果的可靠数据。该回顾性单中心研究包括867名成人移植受者,从2006年到2015年获得肾移植。与对照组相比,我们评估了鉴定的淋巴细胞患者患者的患者和移植物存活,排斥事件或可检测的供体特异性抗体(DNDSA) 。我们确定了305/867(35.2%)淋巴细胞形成患者,其中72/867(8.3%)所需的干预。多变量分析确定了淋巴细胞形成的独立风险因子(或1.61,CI 95%1.17-21,P = 0.003),而延迟接枝函与症状淋巴细胞(或1.9,CI 95%1.16-3.12, p = 0.011)。有趣的是,在10年后,在所有组的群体之间具有相似的移植物和患者存活之间的可检测到的DNDSA没有差异。移植后经常发生淋巴细胞,发现与排斥事件独立相关,而症状淋巴细胞与我们的队列中的延迟接枝功能有关。由于两者都是炎症过程,它们可能在淋巴细胞的形成中发挥致病作用。然而,淋巴细胞的开发或干预在长期内不会导致移植物存活受损。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号